Assure Holdings (IONM) Stock Overview

Through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. More details

IONM fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($2K)

Shares are highly illiquid

Latest financial reports are more than a year old

IONM Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW479,582 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.

Grow your followingReal investors. The kind who actually invest, not scroll past.

Unlock free accessFree premium subscription for consistent and quality authors.

Learn more Create Narrative

479,582 investors already sharing narratives

View all narratives

Assure Holdings Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Assure Holdings
Historical stock prices
Current Share Price	US$0.0005
52 Week High	US$4.20
52 Week Low	US$0.0001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	-98.96%
3 Year Change	-99.90%
5 Year Change	-99.90%
Change since IPO	-99.90%

Recent updates

Seeking Alpha • Aug 22

Assure Holdings stock gains on proposed public offering of common stock

Assure Holdings (NASDAQ:IONM) shares popped ~12.9% after-hours on Friday after the firm said that it intends to offer its shares of common stock in a public offering. Net proceeds from this offering will be used for general corporate purposes. Offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Seeking Alpha • Jul 14

Assure Holdings to continue streamlining business to achieve positive operating cash flow

Assure Holdings (NASDAQ:IONM) said Thursday it will continue streamlining operations, aiming to achieve positive operating cash flow. The news sent IONM shares 12.9% higher aftermarket, but in low trading volumes. Earlier cost cutting measures, as well as the latest ones, will realize $4M of savings on an annualized basis. The measures included reducing workforce, salary cuts for the management, limiting use of outside consultants and reducing operating costs. IONM rationalized its footprint by discontinuing operations at certain low-performing markets. The firm is continuing to invest in its managed care and revenue cycle management functions and tools. IONM will prioritize growth resources in markets with substantial operational density, servicing facility-wide outsourcing deals and enter new markets with strong profitability profiles. "Our plan reduces structural costs while funding long-term improvements that benefit IONM's profitability. We expect the business will be leaner and more profitable in H2 of 2022," said CEO John Farlinger. IONM stock has declined ~72% YTD.

Seeking Alpha • Jul 06

Assure Holdings announces partnership with Hayden IR

Assure Holdings (NASDAQ:IONM) has retained Hayden IR to broaden Assure’s awareness within the investor and financial community and support the Co.’s investor relations program. “We engaged Hayden IR to help us expand our outreach and exposure to the investment community as well as assist with communicating our progress as we continue to grow our business.” said John A. Farlinger, Assure’s executive chairman and CEO.

Seeking Alpha • Feb 17

Investors Are Unsure About Assure, But I Am Not

There are unfounded concerns that private insurance for IONM could be reduced or terminated. The company has improved its operations and demonstrated an ability to grow organically and by acquisitions but the stock price has languished. Assure has entered into a partnership with the second largest GPO in the U.S. giving it access to a larger TAM. Billing and collection problems for out-of-network service providers make for low valuation acquisition targets for Assure. Expected continued record revenue and profitability will bring renewed attention to this stock.

Shareholder Returns

	IONM	US Healthcare	US Market
7D	0%	0.8%	-1.4%
1Y	-99.0%	35.8%	16.4%

Return vs Industry: IONM underperformed the US Healthcare industry which returned 35.8% over the past year.

Return vs Market: IONM underperformed the US Market which returned 16.4% over the past year.

Price Volatility

Is IONM's price volatile compared to industry and market?
IONM volatility
IONM Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.1%
Market Average Movement	7.1%
10% most volatile stocks in US Market	16.3%
10% least volatile stocks in US Market	3.2%

Stable Share Price: IONM's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine IONM's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	John Farlinger	www.assureneuromonitoring.com

Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services in the United States. The company offers services in the areas of neurosurgery, spine, cardiovascular, orthopedic, ear, nose, throat, and other surgical procedures that place the nervous system at risk. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing and collection services to support surgeons and medical facilities during invasive procedures.

Assure Holdings Corp. Fundamentals Summary

How do Assure Holdings's earnings and revenue compare to its market cap?
IONM fundamental statistics
Market cap	US$1.84k
Earnings (TTM)	-US$22.22m
Revenue (TTM)	n/a

0.0x

P/S Ratio

0.0x

P/E Ratio

Is IONM overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IONM income statement (TTM)
Revenue	-US$4.27m
Cost of Revenue	US$1.78m
Gross Profit	-US$6.05m
Other Expenses	US$16.17m
Earnings	-US$22.22m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did IONM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/07/23 21:04
End of Day Share Price	2026/06/22 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Assure Holdings Corp. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
William Sutherland	Benchmark Company
Scott Henry	Roth Capital Partners
James Sidoti	Sidoti & Company, LLC

Assure Holdings (IONM) Stock Overview

Risk Analysis

Join community and earn perks

Assure Holdings Corp. Competitors

STRATA Skin Sciences

Medical Care Technologies

Mobile-health Network Solutions

NewGenIvf Group

Price History & Performance

Recent News & Updates

Assure Holdings Corp. announced delayed 10-Q filing

Assure Holdings Corp. Announces Chief Financial Officer Changes

Assure Holdings Corp. has withdrawn its Follow-on Equity Offering in the amount of $23.203125 million.

Assure Holdings Corp. announced delayed 10-Q filing

Assure Holdings Corp.(OTCPK:IONM) dropped from S&P TMI Index

Assure Holdings Corp.(OTCPK:IONM) dropped from NASDAQ Composite Index

Recent updates

Assure Holdings Corp. announced delayed 10-Q filing

Assure Holdings Corp. Announces Chief Financial Officer Changes

Assure Holdings Corp. has withdrawn its Follow-on Equity Offering in the amount of $23.203125 million.

Assure Holdings Corp. announced delayed 10-Q filing

Assure Holdings Corp.(OTCPK:IONM) dropped from S&P TMI Index

Assure Holdings Corp.(OTCPK:IONM) dropped from NASDAQ Composite Index

Nasdaq Hearing Panel Determines to Delist Common Stock of Assure Holdings

Assure Holdings Receives Non-Compliance Notice Regarding 10-Q Filing for the Period Ended March 31, 2024

Assure Holdings Corp. announced delayed 10-Q filing

Nasdaq Hearings Panel Grants Assure Holdings an Extension to Regain Compliance with the Continued Listing Requirements for The Nasdaq Capital Market

Assure Holdings Receives Notice from Nasdaq Due to Delinquency in the Timely Filing of the Annual Report on Form 10-K for the Fiscal Year Ended December 31, 2023 Under Nasdaq Listing Rule 5250(c)(1)

Assure Holdings Corp. announced delayed annual 10-K filing

Danam Health, Inc. entered into a definitive agreement and plan of merger to acquire Assure Holdings Corp. (NasdaqCM:IONM) in a reverse merger transaction.

Assure Holdings Corp. Announces to Appoint Suren Ajjarapu as Chairman

Assure Holdings Corp. Receives A Determination Letter from Listing Qualifications Staff of Nasdaq

Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with Nasdaq Listing Rule 5250(c)(1)

Assure Holdings Corp. announced delayed 10-Q filing

Nasdaq Grants an Extension of Time to Assure Holdings to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement

Assure Holdings Receives Non-Compliance Notice from Nasdaq Regarding Non-Compliance with $2.5 Million Stockholders’ Equity Requirement for Continued Listing on The Nasdaq Capital Market

Assure Holdings Corp. to Report Q2, 2023 Results on Aug 14, 2023

Assure Holdings Corp. (NasdaqCM:IONM) completed the acquisition of Certain Assets from Innovation Neuromonitoring, LLC for $1.2 million.

Assure Holdings Receives Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement as Set Forth in Nasdaq Listing Rule 5550(a)(2)

Assure Holdings Corp. (NasdaqCM:IONM) signed a Letter of Intent to acquire Certain Assets from Innovation Neuromonitoring, LLC for $1.2 million.

Assure Holdings Corp. has completed a Follow-on Equity Offering in the amount of $6 million.

Assure Holdings Corp. Provides Revenue Guidance for the Fourth Quarter of 2022

Assure Holdings Corp., Annual General Meeting, Dec 28, 2022

Assure Holdings Corp. to Report Q3, 2022 Results on Nov 14, 2022

Assure Holdings Corp. Announces Executive Changes

Assure Holdings Receives Letter from the Listing Qualifications Staff of Nasdaq

Assure Holdings Corp. has completed a Follow-on Equity Offering in the amount of $6.245217 million.

Assure Holdings stock gains on proposed public offering of common stock

Assure Holdings Corp. to Report Q2, 2022 Results on Aug 15, 2022

Assure Holdings to continue streamlining business to achieve positive operating cash flow

Assure Holdings announces partnership with Hayden IR

Assure Holdings Corp. Provides Operational Guidance for the Year 2022

Assure Holdings Corp. to Report Q1, 2022 Results on May 16, 2022

Assure Holdings Corp. Appoints James Watt as National Technologist Director

Assure Holdings Corp. Announces Management Change

Investors Are Unsure About Assure, But I Am Not

Assure Announces Voluntary Delisting from TSX Venture Exchange

Assure Holdings Corp. announced that it has received $0.435157 million in funding

Assure Holdings Corp. announced that it expects to receive $0.435157 million in funding

Third quarter 2021 earnings released: EPS US$0.008 (vs US$0.14 loss in 3Q 2020)

Price target decreased to US$17.00

Assure Holdings Corp. announced that it expects to receive $11 million in funding from Centurion Financial Trust

Assure Holdings Corp. Raises Production Guidance for the Year 2021

Assure Holdings Corp. (TSXV:IOM) completed the acquisition of all assets of Sentry Neuromonitoring, LLC.

Assure Holdings Corp. Provides Production Guidance for the Year 2021

Assure Holdings Corp. Appoints Isador Lieberman to its Medical Advisory Committee

Assure Holdings Corp. (TSXV:IOM) signed a term sheet to acquire Sentry Neuromonitoring, LLC for $3.5 million.

Assure Holdings Corp. Adds New Surgeons to its Platform in Arizona

Assure Holdings Corp. announced that it has received $10.46893 million in funding from Manchester Management Company, LLC and other investors

Assure Holdings Corp. announced that it expects to receive $10.28096 million in funding

Assure Holdings Corp. to Report Q3, 2020 Results on Nov 30, 2020

Assure Holdings Corp. Promotes Craig Caviness to Vice President of Corporate Development from His Former Role as Eastern U.S. Territory Director

Assure Holdings Corp. announced that it expects to receive $0.0405 million in funding

Assure Holdings Corp. to Report Q2, 2020 Results on Aug 28, 2020

Assure Holdings Corp. announced a financing transaction

Assure Holdings Corp. to Report Q1, 2020 Results on Jul 14, 2020

Shareholder Returns

Price Volatility

About the Company

Assure Holdings Corp. Fundamentals Summary